Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Cryopreservation
100%
Confidence Interval
100%
Overall Survival
100%
Graft-versus-host Disease Prophylaxis
100%
Post-transplantation Cyclophosphamide (PTCy)
100%
Hazard Ratio
61%
Cryopreserved Graft
38%
Graft-versus-host Disease (GvHD)
30%
Cryopreserved
23%
Non-relapse Mortality
23%
Hematological Malignancies
15%
Disease Risk Prediction
15%
Disease-free Survival
15%
Mortality Hazard
15%
Multiple Comparisons
15%
Karnofsky Performance Status
15%
Propensity Score
15%
Histology
7%
Disease Diagnosis
7%
High Risk
7%
Mortality Risk
7%
Cell Collection
7%
Risk Index
7%
Pretransplant
7%
COVID-19 Pandemic
7%
Conditioning Regimen
7%
Donor Cells
7%
Logistic Regression
7%
Low Dose Rate
7%
P-12
7%
Non-associated
7%
Donor-recipient Matching
7%
Statistical Significance
7%
Regression Analysis
7%
Hematopoietic Recovery
7%
Donor Graft
7%
Neutrophil Recovery
7%
Progression-free Survival
7%
Donor Type
7%
Graft Source
7%
Conditioning Intensity
7%
Marrow Transplantation
7%
Bone Marrow Graft
7%
Treatment Failure
7%
Platelet Recovery
7%
Recovery Increase
7%
Peripheral Blood Stem Cell Graft
7%
P-27
7%
Graft Type
7%
Source Intensity
7%
Comorbidity Index
7%
P-32
7%
Risk Propensity
7%
Donor Evaluation
7%
Cell Grafting
7%
Medicine and Dentistry
Cell Transplantation
100%
Prophylaxis
100%
Cyclophosphamide
100%
Cryopreservation
100%
Hazard Ratio
100%
Overall Survival
100%
Hematopoietic Stem Cell
100%
Graft Versus Host Reaction
100%
Allogeneic Hematopoietic Stem Cell Transplantation
62%
Disease
25%
Hematologic Malignancy
25%
Acute Graft Versus Host Disease
25%
Chronic Graft Versus Host Disease
25%
Conditioning
25%
Disease Free Survival
25%
Karnofsky Performance Status
25%
Transplantation
12%
Diagnosis
12%
Platelet
12%
Neutrophil
12%
Bone Marrow Transplantation
12%
Peripheral Blood Stem Cell
12%
Infusion
12%
COVID-19
12%
Logistic Regression Analysis
12%
Progression Free Survival
12%
Transplantation Conditioning
12%
Nursing and Health Professions
Prophylaxis
100%
Confidence Interval
100%
Cell Transplantation
100%
Overall Survival
100%
Graft Versus Host Reaction
100%
Cyclophosphamide
100%
Cryopreservation
100%
Hazard Ratio
61%
Allogeneic Hematopoietic Stem Cell Transplantation
38%
Propensity Score
15%
Chronic Graft Versus Host Disease
15%
Hematologic Malignancy
15%
Acute Graft Versus Host Disease
15%
Karnofsky Performance Status
15%
Disease Free Survival
15%
Disease
15%
Treatment Failure
7%
Comorbidity
7%
Transplantation
7%
Bone Marrow Transplantation
7%
Diagnosis
7%
Infusion
7%
Pandemic
7%
Logistic Regression Analysis
7%
Progression Free Survival
7%
Transplantation Conditioning
7%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Cell Transplantation
100%
Overall Survival
100%
Hematopoietic Cell
100%
Cyclophosphamide
100%
Cryopreservation
100%
Allogeneic Hematopoietic Stem Cell Transplantation
83%
Conditioning
50%
Acute Graft Versus Host Disease
33%
Chronic Graft Versus Host Disease
33%
Disease Free Survival
33%
Platelet
16%
COVID-19
16%
Transplant Procedure
16%
Peripheral Blood Stem Cell
16%
Comorbidity
16%
Progression Free Survival
16%
Neutrophil
16%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Cyclophosphamide
100%
Overall Survival
100%
Disease
50%
Hematologic Malignancy
33%
Acute Graft Versus Host Disease
33%
Chronic Graft Versus Host Disease
33%
Disease Free Survival
33%
Comorbidity
16%
Pandemic
16%
Progression Free Survival
16%
Neuroscience
Cyclophosphamide
100%
Hematopoietic Stem Cell
83%
Stem Cell
16%
Platelet
16%